Aastha Chandak

14PUBLICATIONS
22CO-AUTHORS
Social determinants of healthEmergency medicineMajor global burdens of diseaseRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 11, 2026
Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers.

Paul Loubet, Aastha Chandak, Susan Spivey

|Feb 09, 2026
Lower mortality risk associated with remdesivir plus corticosteroids vs corticosteroids alone for the treatment of patients hospitalized with SARS-CoV-2 infection in the early and later Omicron periods.

Alpesh N Amin, Thomas Oppelt, Aastha Chandak

|Oct 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19.

Andre C Kalil, Aastha Chandak, Luke S P Moore

|Oct 18, 2024
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals.

Essy Mozaffari, Aastha Chandak, Mark Berry

|Oct 15, 2024
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb

|Oct 15, 2024
Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.

Essy Mozaffari, Aastha Chandak, Robert L Gottlieb

Pageof 3

Frequent Collaborators

6 joint publications

Robert L Gottlieb

6 joint publications

Andre C Kalil

6 joint publications

Mark Berry

5 joint publications

Roman Casciano